Abstract:Only a limited amount of orally administered lipid nanoparticles are absorbed as intact particles due to lipolysis by lipases in the gastrointestinal tract. It is hypothesized that by counteracting lipolysis, more particles will survive gastrointestinal digestion and be absorbed as intact particles. In this study, incorporation of a lipase inhibitor orlistat (OLST), as well as polyethylene glycol (PEG) coating, is employed to slow down the lipolysis using solid lipid nanoparticles (SLNs) as model particles. To explore the in vivo behaviors of the particles, near-infrared fluorescent probes with absolute aggregation-caused quenching (ACQ) properties are used to label and track the unmodified, PEG-coated and OLST-loaded SLNs. The in vitro lipolysis study indicates very fast first-order degradation of unmodified SLNs and significantly decreased degradation of OLST-SLNs. Live imaging reveals the same trend of slowed-down lipolysis in vivo which correlates well with the in vitro lipolysis. The scanning of ex vivo gastrointestinal segments confirms the considerably prolonged residence time of OLST-SLNs, mirroring the significantly decreased lipolysis rate. The observation of fluorescence in the blood, though very weak, and in the liver speaks of the oral absorption of intact SLNs. The substantially higher hepatic levels of OLST-SLNs than unmodified SLNs should be attributed to the significantly enhanced survival rate because both particles exhibit similar cellular recognition as well as similar physicochemical properties except for the survival rate. Similarly, slowing down lipolysis also contributes to the significantly enhanced cumulative lymphatic transport of OLST-SLNs (7.56% vs. 1.27% for the unmodified SLNs). The PEG coating slows down the lipolysis rate as well but not to the degree as done by OLST. As a result, the gastrointestinal residence time of PEG-SLNs has been moderately prolonged and the hepatic levels moderately increased. The weakened cellular recognition of PEG-SLNs implies that the enhanced oral absorption is solely ascribed to the slowed-down lipolysis and enhanced mucus penetration. In conclusion, the oral absorption of intact SLNs can be significantly enhanced by slowing down lipolysis, especially by OLST, showing potential as carriers for the oral delivery of labile biomacromolecules.

Magnolol Encapsulated by Different Acyl Chain Length of Liposomes on Inhibiting Proliferation of Smooth Muscle Cells

Inhibiting the Vascular Smooth Muscle Cells Proliferation by EPC and DPPC Liposomes Encapsulated Magnolol

Inhibition of Neointimal Hyperplasia in Balloon-Induced Vascular Injuries in a Rat Model by Mir-22 Loading Laponite Hydrogels.

EFFECT OF DRUG INCORPORATION ON THE MORPHOLOGY OF AMPHIPHILIC BLOCK COPOLYMER MICELLES

Alprostadil Liposome Microsphere Preparation Stabilizes Vascular Plaques and Inhibits Intra-Plaque Inflammation.

Methyl Protodioscin, A Steroidal Saponin, Inhibits Neointima Formation In Vitro And In Vivo

ICAM-1-Targeted Liposomes Loaded with Liver X Receptor Agonists Suppress PDGF-Induced Proliferation of Vascular Smooth Muscle Cells

Honokiol-mesoporous Silica Nanoparticles Inhibit Vascular Restenosis Via the Suppression of TGF-β Signaling Pathway.

Investigating Bolalipids As Solubilizing Agents for Poorly Soluble Drugs: Effects of Alkyl Chain Length on Solubilization and Cytotoxicity

Targeted Delivery of Liver X Receptor Agonist to Inhibit Neointimal Hyperplasia by Differentially Regulating Cell Behaviors.

Methylation and Esterification of Magnolol for Ameliorating Cutaneous Targeting and Therapeutic Index by Topical Application

Magnetically targeted lidocaine sustained-release microspheres: optimization, pharmacokinetics, and pharmacodynamic radius of effect

Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation

Mir-22-incorporated Polyelectrolyte Coating Prevents Intima Hyperplasia after Balloon-Induced Vascular Injury.

Effects of Dihydropyridine Calcium Channel Blockers on Oxidized Low-Density Lipoprotein Induced Proliferation and Oxidative Stress of Vascular Smooth Muscle Cells

Osthole Alleviates Neointimal Hyperplasia in Balloon-Induced Arterial Wall Injury by Suppressing Vascular Smooth Muscle Cell Proliferation and Downregulating Cyclin D1/CDK4 and Cyclin E1/CDK2 Expression

Lymphatic Transport of Orally Administered Probucol-Loaded Mpeg-Dspe Micelles

Poly(trimethylene Carbonate)‐b‐poly(ethylene Glycol) Diblock Copolymer Micelles for Hydrophobic Drug Delivery: the Effect of Hydrophilic/hydrophobic Segment Length on Micellar Properties and Drug Loading

Locally administered antiproliferative drugs inhibit hypercontractility to serotonin in balloon-injured pig coronary artery

Targeting and deep-penetrating delivery strategy for stented coronary artery by magnetic guidance and ultrasound stimulation

Slowing down lipolysis significantly enhances the oral absorption of intact solid lipid nanoparticles.